Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis. - El-Mahdy NA; El-Sayad ME; El-Kadem AH; Abu-Risha SE (Fundamental & clinical pharmacology, 2021)